Cargando…

PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation

In this work, a one-shot process for the simultaneous foaming of polycaprolactone (PCL) and impregnation of mesoglycan (MSG) into the porous structure was successfully attempted. Supercritical carbon dioxide plays the role of the foaming agent with respect to PCL and of the solvent with respect to M...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Paola, Belvedere, Raffaella, Pessolano, Emanuela, Liparoti, Sara, Pantani, Roberto, Petrella, Antonello, De Marco, Iolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956126/
https://www.ncbi.nlm.nih.gov/pubmed/31779148
http://dx.doi.org/10.3390/pharmaceutics11120631
_version_ 1783487088272867328
author Franco, Paola
Belvedere, Raffaella
Pessolano, Emanuela
Liparoti, Sara
Pantani, Roberto
Petrella, Antonello
De Marco, Iolanda
author_facet Franco, Paola
Belvedere, Raffaella
Pessolano, Emanuela
Liparoti, Sara
Pantani, Roberto
Petrella, Antonello
De Marco, Iolanda
author_sort Franco, Paola
collection PubMed
description In this work, a one-shot process for the simultaneous foaming of polycaprolactone (PCL) and impregnation of mesoglycan (MSG) into the porous structure was successfully attempted. Supercritical carbon dioxide plays the role of the foaming agent with respect to PCL and of the solvent with respect to MSG. The main objective is to produce an innovative topical device for application on skin lesions, promoting prolonged pro-resolving effects. The obtained device offers a protective barrier to ensure a favorable and sterilized environment for the wound healing process. The impregnation kinetics revealed that a pressure of 17 MPa, a temperature of 35 °C, and a time of impregnation of 24 h assured a proper foaming of PCL in addition to the impregnation of the maximum amount of MSG; i.e., 0.22 mg(MSG)/mg(PCL). After a preliminary study conducted on PCL granules used as brought, the MSG impregnation was performed at the optimized process conditions also on a PCL film, produced by compression molding, with the final goal of producing medical patches. Comparing the dissolution profiles in phosphate buffered saline solution (PBS) of pure MSG and MSG impregnated on foamed PCL, it was demonstrated that the release of MSG was significantly prolonged up to 70 times. Next, we performed functional assays of in vitro wound healing, cell invasion, and angiogenesis to evaluate the biological effects of the PCL-derived MSG. Interestingly, we found the ability of this composite system to promote the activation of human keratinocytes, fibroblasts, and endothelial cells, as the main actors of tissue regeneration, confirming what we previously showed for the MSG alone.
format Online
Article
Text
id pubmed-6956126
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69561262020-01-23 PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation Franco, Paola Belvedere, Raffaella Pessolano, Emanuela Liparoti, Sara Pantani, Roberto Petrella, Antonello De Marco, Iolanda Pharmaceutics Article In this work, a one-shot process for the simultaneous foaming of polycaprolactone (PCL) and impregnation of mesoglycan (MSG) into the porous structure was successfully attempted. Supercritical carbon dioxide plays the role of the foaming agent with respect to PCL and of the solvent with respect to MSG. The main objective is to produce an innovative topical device for application on skin lesions, promoting prolonged pro-resolving effects. The obtained device offers a protective barrier to ensure a favorable and sterilized environment for the wound healing process. The impregnation kinetics revealed that a pressure of 17 MPa, a temperature of 35 °C, and a time of impregnation of 24 h assured a proper foaming of PCL in addition to the impregnation of the maximum amount of MSG; i.e., 0.22 mg(MSG)/mg(PCL). After a preliminary study conducted on PCL granules used as brought, the MSG impregnation was performed at the optimized process conditions also on a PCL film, produced by compression molding, with the final goal of producing medical patches. Comparing the dissolution profiles in phosphate buffered saline solution (PBS) of pure MSG and MSG impregnated on foamed PCL, it was demonstrated that the release of MSG was significantly prolonged up to 70 times. Next, we performed functional assays of in vitro wound healing, cell invasion, and angiogenesis to evaluate the biological effects of the PCL-derived MSG. Interestingly, we found the ability of this composite system to promote the activation of human keratinocytes, fibroblasts, and endothelial cells, as the main actors of tissue regeneration, confirming what we previously showed for the MSG alone. MDPI 2019-11-26 /pmc/articles/PMC6956126/ /pubmed/31779148 http://dx.doi.org/10.3390/pharmaceutics11120631 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Franco, Paola
Belvedere, Raffaella
Pessolano, Emanuela
Liparoti, Sara
Pantani, Roberto
Petrella, Antonello
De Marco, Iolanda
PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title_full PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title_fullStr PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title_full_unstemmed PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title_short PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
title_sort pcl/mesoglycan devices obtained by supercritical foaming and impregnation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956126/
https://www.ncbi.nlm.nih.gov/pubmed/31779148
http://dx.doi.org/10.3390/pharmaceutics11120631
work_keys_str_mv AT francopaola pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT belvedereraffaella pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT pessolanoemanuela pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT liparotisara pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT pantaniroberto pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT petrellaantonello pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation
AT demarcoiolanda pclmesoglycandevicesobtainedbysupercriticalfoamingandimpregnation